Skip to content

Svenningsson lab

Translational Research on Neuropharmacology and Movement Disorders

  • Home
  • News
  • Research
    • Pre-Clinical
      • P11 and G protein-coupled receptor function & pharmacology
      • Proteinopathies
    • Clinical
      • Clinical trials and Biomarkers in Parkinsonism
      • Ataxia, spastic paraparesis, chorea and other movement disorders
      • The role of glycemic control in Parkinson’s disease
  • Publications
  • People
    • Core Pre-Clinical Group
    • Core Clinical Group
    • Join our team
    • Alumni
    • Lab Group photos
  • Funding
  • Outreach
  • För Patienter
  • Contact
Posted on 11 May 202617 May 2026 by Anderson Camargo

Per and Rainer from the OnoPharma team during a meeting in Hamburg

CategoriesUncategorized

Post navigation

Previous PostPrevious New paper in Molecular Psychiatry regarding adenosine signaling on ketamine’s effects.
Next PostNext Alison and lab members celebrating the completion of her Fulbright Program at the U.S. Embassy in Sweden

Postal Address

Karolinska Institutet
NKS, Bioclinicum
Visionsgatan 4
J5:20 Neuro- Svenningsson
Solna, 171 64

Telephone

+46 851774614

Our Karolinska Institute webpage

(Link to our Karolinska Institute webpage)

 

 

Proudly powered by WordPress